APA (7th ed.) Citation

Gulbins, A., Horstmann, M., Daser, A., Flögel, U., Oeverhaus, M., Bechrakis, N. E., . . . Görtz, G. (2023). Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease. Frontiers in endocrinology (Lausanne), 14, 1211473. https://doi.org/10.3389/fendo.2023.1211473

Chicago Style (17th ed.) Citation

Gulbins, Anne, et al. "Linsitinib, an IGF-1R Inhibitor, Attenuates Disease Development and Progression in a Model of Thyroid Eye Disease." Frontiers in Endocrinology (Lausanne) 14 (2023): 1211473. https://doi.org/10.3389/fendo.2023.1211473.

MLA (9th ed.) Citation

Gulbins, Anne, et al. "Linsitinib, an IGF-1R Inhibitor, Attenuates Disease Development and Progression in a Model of Thyroid Eye Disease." Frontiers in Endocrinology (Lausanne), vol. 14, 2023, p. 1211473, https://doi.org/10.3389/fendo.2023.1211473.